Chassieu, March 12, 2026 (GLOBE NEWSWIRE) -- Amoéba receives its first order from Koppert and confirms its transformation into a commercial company Chassieu (France), 11 March 2026 – 6:00 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialised in the development of natural microbiological solutions based on the patented use of amoebae, announces its first order from its partner Koppert, world leader in biocontrol. Amoéba thus becomes a true commercial company, whose biocontrol activities are no ...

Core Insights - Amoéba, a greentech company specializing in natural microbiological solutions, won the gold medal at the SIVAL Innovation 2026 Competition for its biocontrol solution aimed at treating vineyards and vegetable crops, with a commercial launch planned for 2026 pending market authorizations [1][2][3] Company Developments - The AXPERA solution, recognized for its innovative approach to sustainable protection against fungal diseases, will be rebranded as TIAGAN for commercial use in viticulture [2][8] - Amoéba has established a strategic commercial agreement with Koppert, granting exclusive distribution rights for its product in 18 European countries and the United States for five years [4] - The company received the Bernard Blum Gold Medal in October 2025, further solidifying AXPERA's position as a leading biocontrol solution [4] Market Strategy - Amoéba is actively pursuing marketing authorizations for the TIAGAN solution in nine targeted European countries, with decisions expected in the first half of 2026 [7][8] - The company is focusing on building a robust supply chain and ramping up production in preparation for the commercial launch in 2026 [9][10] Industry Recognition - The biocontrol solution has gained significant recognition among industry professionals, particularly for its effectiveness in combating grapevine downy mildew, allowing winegrowers to reduce copper usage [5] - Amoéba was featured in CNN's Innovate series, highlighting its commitment to developing environmentally friendly innovations [6]